Provided by Tiger Fintech (Singapore) Pte. Ltd.

Beam Therapeutics, Inc.

20.17
+1.045.44%
Volume:1.26M
Turnover:25.61M
Market Cap:2.03B
PE:-4.40
High:20.81
Open:20.00
Low:19.98
Close:19.13
Loading ...

Beam Therapeutics Inc - Dosing to Commence in Beam-301 Trial in Early 2025

THOMSON REUTERS
·
13 Jan

Beam Therapeutics Announces Progress in Hematology and Genetic Disease Franchises and Outlines Key 2025 Anticipated Catalysts

THOMSON REUTERS
·
13 Jan

Beam Therapeutics Inc - Over 40 Adult Sickle Cell Patients Enrolled in Beacon Trial

THOMSON REUTERS
·
13 Jan

Beam Therapeutics Inc - Expects to Dose 30 Patients and Present Data by Mid-2025

THOMSON REUTERS
·
13 Jan

Beam Therapeutics Inc - Cash Runway Expected to Support Operations Into 2027

THOMSON REUTERS
·
13 Jan

Beam Therapeutics Inc - Initial Data From Beam-302 Trial Expected in First Half 2025

THOMSON REUTERS
·
13 Jan

Press Release: Beam Therapeutics Announces Progress in Hematology and Genetic Disease Franchises and Outlines Key 2025 Anticipated Catalysts

Dow Jones
·
13 Jan

Beam Therapeutics Inc : Bernstein Raises to Outperform From Market Perform; Raises Target Price to $37 From $35

THOMSON REUTERS
·
07 Jan

Why Is Beam Therapeutics Inc. (BEAM) Among the Top CRISPR Stocks to Invest In?

Insider Monkey
·
31 Dec 2024

Beam Therapeutics Inc. (BEAM): Is This Gene Therapy Stock a Good Buy Right Now?

Insider Monkey
·
29 Dec 2024

5 Biotech Breakthrough Stocks to Watch in 2025

Zacks
·
23 Dec 2024

Cathie Wood’s ARK Investment buys 116K shares of Beam Therapeutics today

TIPRANKS
·
19 Dec 2024

Stock Market Today: Dow Jones Up As Bitcoin Play Pops; Cathie Wood Loads Up On This AI Stock Amid 48% Plunge

Blockhead
·
17 Dec 2024

Why Beam Therapeutics (BEAM) Is the Worst ARK Stock to Buy According to Short Sellers

Insider Monkey
·
12 Dec 2024

Beam Therapeutics: Strong Buy Rating Backed by Promising BEAM-101 Clinical Data in Sickle Cell Disease

TIPRANKS
·
10 Dec 2024

Beam Therapeutics Unveils New Safety, Efficacy Data From Sickle Cell Disease Candidate, Stock Gains

Benzinga
·
10 Dec 2024

Sector Update: Health Care Stocks Edge Higher Pre-Bell Monday

MT Newswires Live
·
09 Dec 2024

Exchange-Traded Funds Lower, Equity Futures Mixed Pre-Bell Monday Ahead of Crucial Inflation Data

MT Newswires Live
·
09 Dec 2024

Beam Therapeutics Appoints Sravan Emany as New CFO, Shares Up

Zacks
·
09 Dec 2024

Scotiabank Keeps Their Hold Rating on Beam Therapeutics (BEAM)

TIPRANKS
·
09 Dec 2024